BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33048927)

  • 1. Quantitative analysis questions the role of MeCP2 as a global regulator of alternative splicing.
    Chhatbar K; Cholewa-Waclaw J; Shah R; Bird A; Sanguinetti G
    PLoS Genet; 2020 Oct; 16(10):e1009087. PubMed ID: 33048927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
    Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
    Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
    Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losing Dnmt3a dependent methylation in inhibitory neurons impairs neural function by a mechanism impacting Rett syndrome.
    Lavery LA; Ure K; Wan YW; Luo C; Trostle AJ; Wang W; Jin H; Lopez J; Lucero J; Durham MA; Castanon R; Nery JR; Liu Z; Goodell M; Ecker JR; Behrens MM; Zoghbi HY
    Elife; 2020 Mar; 9():. PubMed ID: 32159514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome.
    Li R; Dong Q; Yuan X; Zeng X; Gao Y; Chiao C; Li H; Zhao X; Keles S; Wang Z; Chang Q
    PLoS Genet; 2016 Jun; 12(6):e1006129. PubMed ID: 27352031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal non-CG methylation is an essential target for MeCP2 function.
    Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
    Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders.
    Bach S; Ryan NM; Guasoni P; Corvin AP; El-Nemr RA; Khan D; Sanfeliu A; Tropea D
    Sci Rep; 2020 Dec; 10(1):22255. PubMed ID: 33335218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rett syndrome and MeCP2.
    Liyanage VR; Rastegar M
    Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-specific DNA binding by AT-hook motifs in MeCP2.
    Lyst MJ; Connelly J; Merusi C; Bird A
    FEBS Lett; 2016 Sep; 590(17):2927-33. PubMed ID: 27461740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
    Pejhan S; Rastegar M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2 gates spatial learning-induced alternative splicing events in the mouse hippocampus.
    Brito DVC; Gulmez Karaca K; Kupke J; Frank L; Oliveira AMM
    Mol Brain; 2020 Nov; 13(1):156. PubMed ID: 33203444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome.
    Brown K; Selfridge J; Lagger S; Connelly J; De Sousa D; Kerr A; Webb S; Guy J; Merusi C; Koerner MV; Bird A
    Hum Mol Genet; 2016 Feb; 25(3):558-70. PubMed ID: 26647311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
    Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
    BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.
    Young JI; Hong EP; Castle JC; Crespo-Barreto J; Bowman AB; Rose MF; Kang D; Richman R; Johnson JM; Berget S; Zoghbi HY
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17551-8. PubMed ID: 16251272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain.
    Lagger S; Connelly JC; Schweikert G; Webb S; Selfridge J; Ramsahoye BH; Yu M; He C; Sanguinetti G; Sowers LC; Walkinshaw MD; Bird A
    PLoS Genet; 2017 May; 13(5):e1006793. PubMed ID: 28498846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.